Patient treated at the first clinical contact~18 sites (hospitals) in France~Treatment during 48 weeks with principal objective at W24 (plasma HIV-RNA < 50 copies/ml)~Evaluation of antiretroviral treatment adherence using determination of Bictegravir, Emtricitabine and Tenofovir in hair sample
Evaluation of antiretroviral treatment adherence using determination of Bictegravir, Emtricitabine and Tenofovir with new HIV patients in France